je.st
news
J&J strikes Alzheimer's deal with AC Immune worth up to $509M
2015-01-13 06:36:02| Biotech - Topix.net
Johnson & Johnson boosted its research efforts in Alzheimer's on Monday by striking a deal potentially worth up to $509 million with unlisted Swiss biotech firm AC Immune to develop so-called anti-tau vaccines. Tau is a protein known for forming tangles inside brain cells and is linked to cell death.
Tags: to
deal
worth
immune
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|